At the 2024 Academy Awards, Eli Lilly, the manufacturer of blockbuster weight loss drugs including Mounjaro and Zepbound, criticized people for taking GLP-1s without an obesity diagnosis. In 2025, the pharma giant is changing tack with an attack on its non-FDA-approved rivals. “Healthy Skepticism,” from Wieden+Kennedy, will debut at the 97th Academy Awards on Sunday,…Read More